Boston Scientific
1,067 hedge funds and large institutions have $71.6B invested in Boston Scientific in 2023 Q2 according to their latest regulatory filings, with 135 funds opening new positions, 399 increasing their positions, 360 reducing their positions, and 63 closing their positions.
114% more first-time investments, than exits
New positions opened: 135 | Existing positions closed: 63
15% more funds holding in top 10
Funds holding in top 10: 26 → 30 (+4)
11% more repeat investments, than reductions
Existing positions increased: 399 | Existing positions reduced: 360
9% more capital invested
Capital invested by funds: $65.7B → $71.6B (+$5.87B)
7% more funds holding
Funds holding: 996 → 1,067 (+71)
0.91% less ownership
Funds ownership: 91.48% → 90.57% (-0.91%)
9% less call options, than puts
Call options by funds: $295M | Put options by funds: $326M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$285M |
| 2 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$230M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$227M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$215M |
| 5 |
Amundi
Paris,
France
|
+$142M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$549M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$543M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$353M |
| 4 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$206M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$139M |
BSX Hedge Fund Activity: Q2 2023 in Review
1,067 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2023, worth a combined $71.6B — up 8.9% from $65.7B a quarter earlier.
Buyers outnumbered sellers: 135 funds opened new BSX positions and 63 closed out — a net gain of 72 holders — while 399 added to existing stakes and 360 trimmed.
The largest buyer was Invesco, adding an estimated $285M. The largest seller was JP Morgan Chase, cutting an estimated $549M.
- 1,067 institutional investors held Boston Scientific (BSX) as of Q2 2023, up from 996 in Q1 2023.
- Funds reported $71.6B of Boston Scientific stock for Q2 2023, up 8.9% quarter-over-quarter.
- 135 funds opened new Boston Scientific positions in Q2 2023 and 63 closed out, a net change of +72 holders.
- The largest Boston Scientific buyer in Q2 2023 was Invesco, an estimated $285M added.
- The largest Boston Scientific seller in Q2 2023 was JP Morgan Chase, an estimated $549M sold.
Based on aggregated 13F filings for Q2 2023.